Russell Investments Group, Ltd. Surface Oncology, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$2.65 - $5.08 $24,486 - $46,939	9,240 New	9,240 $27,000
Q4 2019 Jan 29, 2020	SELL	$1.17 - $2.33 $8,083 - $16,097	-6,909 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$1.4 - $2.84 $249 - $505	-178 Reduced 2.51%	6,909 $10,000
Q2 2019 Aug 09, 2019	BUY	$2.75 - $4.89 $500 - $889	182 Added 2.64%	7,087 $20,000
Q1 2019 May 13, 2019	BUY	$4.11 - $5.88 $13,994 - $20,021	3,405 Added 97.29%	6,905 $33,000
Q4 2018 Feb 11, 2019	BUY	$3.65 - $10.69 $12,775 - $37,415	3,500 New	3,500 $15,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.